Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32024-08-19NCT06187441

1 results · Page 1 of 1

Swipe the table sideways for more columns.

38 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alrijne Ziekenhuis LeiderdorpLeiderdorpNetherlands2
HMC AntoniushoveLeidschendamNetherlands1
Nij Smellinghe ZiekenhuisDrachtenNetherlands3
NL-Almere-FlevoziekenhuisAlmere StadNetherlands4
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam- UMCAmsterdamNetherlands1
NL-Amsterdam-AMSTERDAMUMCAmsterdamNetherlands3
NL-Apeldoorn-GELREAPELDOORNApeldoornNetherlands3
NL-Arnhem-RIJNSTATEArnhemNetherlands11
NL-Assen-WZAAssenNetherlands1
NL-Beverwijk-RKZBeverwijkNetherlands1
NL-Delft-RDGGDelftNetherlands8
NL-Den Bosch-JBZ's-HertogenboschNetherlands14
NL-Deventer-DZDeventerNetherlands1
NL-Dordrecht-ASZDordrechtNetherlands14
NL-Ede-ZGVEdeNetherlands6
NL-Emmen-SCHEPEREmmenNetherlands1
NL-Enschede-MSTEnschedeNetherlands11
NL-Goes-ADRZGoesNetherlands5
NL-Gorinchem-BEATRIXGorinchemNetherlands1
NL-Groningen-MARTINIGroningenNetherlands2
NL-Hardenberg-SAXENBURGHHardenbergNetherlands1
NL-Harderwijk-STJANSDALHARDERWIJKHarderwijkNetherlands2
NL-Helmond-ELKERLIEKHelmondNetherlands1
NL-Hilversum-TERGOOIHilversumNetherlands4